Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement

被引:8
|
作者
Swiderek-Matysiak, Mariola [1 ]
Oset, Magdalena [1 ]
Domowicz, Malgorzata [1 ]
Galazka, Grazyna [1 ]
Namiecinska, Magdalena [1 ]
Stasiolek, Mariusz [1 ]
机构
[1] Med Univ Lodz, Dept Neurol, Kosciuszki St 4, PL-90419 Lodz, Poland
关键词
multiple sclerosis; differential diagnosis; cerebrospinal fluid; oligoclonal bands; neurofilaments light chain; interleukin; 6; osteopontin; FIBRILLARY ACIDIC PROTEIN; NEUROMYELITIS-OPTICA; LUPUS-ERYTHEMATOSUS; OSTEOPONTIN LEVELS; MISDIAGNOSIS; NEUROFILAMENT; CXCL13; SPECIFICITY; MARKERS; CSF;
D O I
10.3390/biomedicines11020425
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In total, 242 CSF samples were collected from patients undergoing differential MS diagnosis because of the presence of T2-hyperintensive lesions on brain MRI. The non-MS patients were subdivided into systemic inflammatory diseases with CNS involvement (SID) or cerebrovascular diseases (CVD) or other non-inflammatory diseases (NID). All samples were analyzed for the presence of oligoclonal bands and ELISA was performed for detection of: INF gamma, IL-6, neurofilaments light chain (NF-L), GFAP, CHI3L1, CXCL13, and osteopontin. Results: The level of IL-6 (p = 0.024), osteopontin (p = 0.0002), and NF-L (p = 0.002) was significantly different among groups. IL-6 (p = 0.0350) and NF-L (p = 0.0015) level was significantly higher in SID compared to NID patients. A significantly higher level of osteopontin (p = 0.00026) and NF-L (p = 0.002) in MS compared to NID population was noted. ROC analysis found weak diagnostic power for osteopontin and NFL-L. Conclusions: The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis
    Eckstein, Christopher
    Saidha, Shiv
    Levy, Michael
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 801 - 816
  • [2] Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis
    Avsar, Timucin
    Korkmaz, Didem
    Tutuncu, Melih
    Demirci, N. Onat
    Saip, Sabahattin
    Kamasak, Mustafa
    Siva, Aksel
    Turanli, Eda Tahir
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (08) : 1081 - 1091
  • [3] Cerebrospinal fluid biomarkers in multiple sclerosis
    Tumani, Hayrettin
    Hartung, Hans-Peter
    Hemmer, Bernhard
    Teunissen, Charlotte
    Deisenhammer, Florian
    Giovannoni, Gavin
    Zettl, Uwe K.
    NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 117 - 127
  • [4] Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
    Wullschleger, Alexandre
    Kapina, Viktoria
    Molnarfi, Nicolas
    Courvoisier, Delphine S.
    Seebach, Joerg D.
    Santiago-Raber, Marie-Laure
    Hochstrasser, Denis F.
    Lalive, Patrice H.
    PLOS ONE, 2013, 8 (08):
  • [5] Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system
    Oreja-Guevara, C
    Sindern, E
    Raulf-Heimsoth, M
    Malin, JP
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (05): : 310 - 313
  • [6] A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis
    Christopher Eckstein
    Shiv Saidha
    Michael Levy
    Journal of Neurology, 2012, 259 : 801 - 816
  • [7] Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases
    Wildner, Paula
    Stasiolek, Mariusz
    Matysiak, Mariola
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 37
  • [8] Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis
    Virgilio, Eleonora
    Vecchio, Domizia
    Crespi, Ilaria
    Puricelli, Chiara
    Barbero, Paolo
    Galli, Giulia
    Cantello, Roberto
    Dianzani, Umberto
    Comi, Cristoforo
    JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3249 - 3257
  • [9] Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
    Lo Sasso, Bruna
    Agnello, Luisa
    Bivona, Giulia
    Bellia, Chiara
    Ciaccio, Marcello
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [10] Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system - value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis
    Reske, D
    Petereit, HF
    Heiss, WD
    ACTA NEUROLOGICA SCANDINAVICA, 2005, 112 (04): : 207 - 213